Enzolytics and Samsung Biologics Announce Dev and Mfg Agreement for Anti SARS-CoV-2 Antibody Therapies.
Samsung Biologics committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, announced the signing...
|